Renaissance Technologies’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-621,200
Closed -$81.9M 4004
2025
Q1
$81.9M Buy
621,200
+306,700
+98% +$40.5M 0.12% 196
2024
Q4
$26.3M Buy
314,500
+118,300
+60% +$9.88M 0.04% 537
2024
Q3
$14.4M Sell
196,200
-26,200
-12% -$1.92M 0.02% 848
2024
Q2
$15.2M Buy
222,400
+125,700
+130% +$8.61M 0.03% 716
2024
Q1
$6.69M Sell
96,700
-55,700
-37% -$3.85M 0.01% 1227
2023
Q4
$10.9M Sell
152,400
-111,600
-42% -$7.99M 0.02% 902
2023
Q3
$13.8M Buy
264,000
+23,500
+10% +$1.22M 0.02% 746
2023
Q2
$15.2M Buy
+240,500
New +$15.2M 0.02% 807
2020
Q2
Sell
-151,400
Closed -$2.33M 3828
2020
Q1
$2.33M Buy
+151,400
New +$2.33M ﹤0.01% 1973
2019
Q3
Sell
-82,300
Closed -$1.07M 3774
2019
Q2
$1.07M Sell
82,300
-1,600
-2% -$20.8K ﹤0.01% 2645
2019
Q1
$1.02M Sell
83,900
-55,900
-40% -$681K ﹤0.01% 2660
2018
Q4
$1.59M Buy
139,800
+93,400
+201% +$1.06M ﹤0.01% 2349
2018
Q3
$1.01M Sell
46,400
-279,076
-86% -$6.06M ﹤0.01% 2602
2018
Q2
$5.75M Sell
325,476
-219,524
-40% -$3.88M 0.01% 1696
2018
Q1
$11.5M Sell
545,000
-30,300
-5% -$638K 0.01% 1274
2017
Q4
$8.33M Buy
575,300
+173,700
+43% +$2.52M 0.01% 1489
2017
Q3
$6.34M Buy
401,600
+151,000
+60% +$2.38M 0.01% 1611
2017
Q2
$3.11M Sell
250,600
-25,400
-9% -$315K ﹤0.01% 2005
2017
Q1
$4.49M Buy
+276,000
New +$4.49M 0.01% 1749
2016
Q2
Sell
-233,900
Closed -$6.5M 3544
2016
Q1
$6.5M Buy
233,900
+189,200
+423% +$5.26M 0.01% 1444
2015
Q4
$2.4M Sell
44,700
-138,391
-76% -$7.44M 0.01% 1996
2015
Q3
$7.33M Buy
+183,091
New +$7.33M 0.02% 1125
2015
Q2
Sell
-43,000
Closed -$1.03M 3422
2015
Q1
$1.03M Buy
+43,000
New +$1.03M ﹤0.01% 2295